[1]
A. Pataco, B. Pimentel, M. Lagarto, A. Félix, and C. Cunha, “Immune-Mediated Diabetes Induced by Dostarlimab: A Case Report”, Acta Med Port, vol. 39, no. 5, pp. 357–359, Nov. 2025.